Frontlight ResearchEarly access
Liver and biliary tract cancer trials in United States
302 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleReal-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
- Where
- Allentown, Altamonte Springs, Austin, Baltimore, Boston, Celebration, Centerville, Chicago, Cleveland, Columbus, Detroit, Fort Myers, Fullerton, Gainesville, Los Angeles, Madison, Manhasset, Miami, Mission Viejo, Mobile, Newport Beach, New York, Reno, Richmond, Rochester, San Francisco, Santa Monica, Seattle, Shreveport, Winston-Salem, Wyoming
- Age
- 22 years and over
- People
- 5,000
- Run by
- HistoSonics, Inc.
See details and how to joinNCT06486454 - No phaseTaking peopleThe Vanguard Study: Testing a New Way to Screen for Cancer
- Where
- Bethesda, Brownstown, Chapel Hill, Charlottesville, Chesterfield, Cheyenne Wells, Cleveland, Clinton Township, Dearborn, Denver, Detroit, Durham, Fairfax, Fort Collins, Greeley, Grosse Pointe Farms, Honolulu, Kansas City, Lafayette, Livonia, Lone Tree, Loveland, Milwaukee, Minneapolis, Norfolk, Novi, Oklahoma City, Pleasanton, Plymouth, Portsmouth, Richmond, Royal Oak, San Diego, South Hill, Springfield, Sterling Heights, St Louis, Tacoma, Troy, West Bloomfield, Wyandotte
- Age
- 45 years to 75 years
- People
- 24,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06995898 - No phaseTaking peopleCREO - Microwave Ablation Feasibility Study
- Where
- Chicago, Gilbert, Houston, Knoxville, Los Angeles, Morgantown
- Age
- 18 years and over
- People
- 75
- Run by
- Banner Health
See details and how to joinNCT07817147 - Phase 3Taking peopleD07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
- Where
- Cleveland, Dallas, Miami Beach, Tucson
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- InnoPharmax Inc.
See details and how to joinNCT06622057 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Birmingham, Boston, Cleveland, Detroit, Duarte, Farmington Hills, Fort Myers, Houston, Madison, Nashville, Seattle
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - Phase 2Not yet taking people in United StatesA Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
- Where
- Birmingham
- Age
- 18 years and over
- People
- 29
- Run by
- Mehmet Akce
See details and how to joinNCT06855225 - No phaseTaking peopleDistance-Based Exercise to Preserve Function and Prevent Disability
- Where
- Boston, Butler, Cranberry Township, Dublin, Fremont, Fresno, Indiana, Kernersville, Mechanicsville, Midlothian, Modesto, Mount Airy, New Castle, Oakland, Pittsburgh, Richmond, Sacramento, San Francisco, San Jose, San Rafael, Santa Clara, Santa Rosa, Seneca, Vallejo, Walnut Creek, Winston-Salem
- Age
- 18 years and over
- People
- 104
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT07059884 - Phase 1Taking peopleA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Boston, Dallas, Detroit, Durham, Glen Burnie, Grand Rapids, Houston, Indianapolis, Madison, Miami, Newport Beach, New York, Philadelphia, Rochester, Stanford, St Louis, Tampa
- Age
- 18 years and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - Phase 2Taking peopleGemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
- Where
- New York
- Age
- 18 years and over
- People
- 20
- Run by
- Columbia University
See details and how to joinNCT07433673 - No phaseNot yet taking people in United StatesCharacterizing Tumor Hypoxia With BOLD-MRI to Predict Y-90 Treatment Response
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 12
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07916376 - Phase 1/2Taking peopleA Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
- Where
- Los Angeles, Scottsdale
- Age
- 18 years to 75 years
- People
- 111
- Run by
- VM Discovery, Inc.
See details and how to joinNCT07636785 - No phaseTaking peopleTargeted Navigation in Hepatocellular Carcinoma (HCC)
- Where
- Miami
- Age
- 18 years and over
- People
- 210
- Run by
- University of Miami
See details and how to joinNCT06260943 - Phase 2Not yet taking people in United StatesZolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers
- Where
- Birmingham
- Age
- 18 years and over
- People
- 32
- Run by
- Midhun Malla
See details and how to joinNCT07723534 - No phaseTaking peopleDNP-MRSI of HCC Metabolism to Predict Therapeutic Response
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 232
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT07807475 - Phase 1/2Taking peopleCR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- Austin, Dallas, Fairfax
- Age
- 18 years and over
- People
- 219
- Run by
- Crescent Biopharma, Inc.
See details and how to joinNCT07909031 · EU 2026-527289-54-00 - Phase 1/2Taking peopleA Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05849480 - Phase 1Taking peopleA DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
- Where
- Baltimore
- Age
- 12 years and over
- People
- 27
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07430202 - Phase 2Taking peopleCombination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma
- Where
- Madison
- Age
- 18 years and over
- People
- 12
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT07766187 - No phaseTaking peopleObtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
- Where
- Bethesda
- Age
- 2 years and over
- People
- 1,800
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01915225 - No phaseTaking peopleCancer Experience Registry (CER) for Cancer Patients and Caregivers
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 15,000
- Run by
- Cancer Support Community, Research and Training Institute, Philadelphia
See details and how to joinNCT02333604 - Phase 1/2Taking peopleA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Aurora, Gainesville, Houston, Los Angeles, Madison, Marietta, Miami Beach, Mineola, New York, Roanoke, Washington D.C.
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - Phase 2Taking people18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146 - Phase 2Taking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Anderson, Atlanta, Bethesda, Charleston, Florida City, Houston, Lincoln, Los Angeles, New York, Portland, Puyallup, Spokane, Virginia Beach, Wheat Ridge
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - Phase 1/2CompletedBOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Santa Monica, Tampa
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470